Pegah Jafari, Sedighe Baghernia, Mehdi Moghanibashi, Parisa Mohamadynejad
{"title":"MIR137基因可变数串联重复多态性rs58335419与胃癌和结肠癌风险的显著相关性","authors":"Pegah Jafari, Sedighe Baghernia, Mehdi Moghanibashi, Parisa Mohamadynejad","doi":"10.3389/bjbs.2021.10095","DOIUrl":null,"url":null,"abstract":"<p><p><b>The purpose of the article:</b> The MIR137 gene acts as a tumor-suppressor gene in colon and gastric cancers. The aim of this study was to investigate the association of functional variable number tandem repeat (VNTR) polymorphism rs58335419 locating in the upstream of the MIR137 gene with the risk of colon and gastric cancers. <b>Materials and methods:</b> Totally, 429 individuals were contributed in the study, including 154 colon and 120 gastric cancer patients and 155 healthy controls. The target VNTR was genotyped using PCR and electrophoresis for all samples. Statistical analysis was performed using SPSS 21.0 software and by T, χ2 and logistic regression tests. <b>Results:</b> Excluding the rare genotypes, our results showed that genotype 3/5 (95% CI = 1.08-3.73, OR = 2.01, <i>p</i> = 0.026) significantly increased the risk of colon cancer but not gastric cancer (95% CI = 0.88-3.30, OR = 1.70, <i>p</i> = 0.114). Also, in the stratification analysis for VNTRs and sex, genotypes 3/4 (95% CI = 1.00-6.07, OR = 2.46, <i>p</i> = 0.049) and 3/5 (95% CI = 1.25-7.18, OR = 2.99, <i>p</i> = 0.014) significantly increased the risk of colon cancer in men but not in women. In addition, all genotypes including the rare genotypes as a group, significantly increase the risk of gastric (95% CI = 1.14-3.00, OR = 1.85, <i>p</i> = 0.012) and colon (95% CI = 1.38-3.43, OR = 2.17, <i>p</i> = 0.001) cancers compared to the genotype 3/3 as a reference. <b>Conclusion:</b> The results show that increasing the copy of VNTR in the MIR137 gene, increases the risk of colon and gastric cancers and can serve as a marker for susceptibility to colon and gastric cancers.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2022-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915678/pdf/","citationCount":"1","resultStr":"{\"title\":\"Significant Association of Variable Number Tandem Repeat Polymorphism rs58335419 in the MIR137 Gene With the Risk of Gastric and Colon Cancers.\",\"authors\":\"Pegah Jafari, Sedighe Baghernia, Mehdi Moghanibashi, Parisa Mohamadynejad\",\"doi\":\"10.3389/bjbs.2021.10095\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>The purpose of the article:</b> The MIR137 gene acts as a tumor-suppressor gene in colon and gastric cancers. The aim of this study was to investigate the association of functional variable number tandem repeat (VNTR) polymorphism rs58335419 locating in the upstream of the MIR137 gene with the risk of colon and gastric cancers. <b>Materials and methods:</b> Totally, 429 individuals were contributed in the study, including 154 colon and 120 gastric cancer patients and 155 healthy controls. The target VNTR was genotyped using PCR and electrophoresis for all samples. Statistical analysis was performed using SPSS 21.0 software and by T, χ2 and logistic regression tests. <b>Results:</b> Excluding the rare genotypes, our results showed that genotype 3/5 (95% CI = 1.08-3.73, OR = 2.01, <i>p</i> = 0.026) significantly increased the risk of colon cancer but not gastric cancer (95% CI = 0.88-3.30, OR = 1.70, <i>p</i> = 0.114). Also, in the stratification analysis for VNTRs and sex, genotypes 3/4 (95% CI = 1.00-6.07, OR = 2.46, <i>p</i> = 0.049) and 3/5 (95% CI = 1.25-7.18, OR = 2.99, <i>p</i> = 0.014) significantly increased the risk of colon cancer in men but not in women. In addition, all genotypes including the rare genotypes as a group, significantly increase the risk of gastric (95% CI = 1.14-3.00, OR = 1.85, <i>p</i> = 0.012) and colon (95% CI = 1.38-3.43, OR = 2.17, <i>p</i> = 0.001) cancers compared to the genotype 3/3 as a reference. <b>Conclusion:</b> The results show that increasing the copy of VNTR in the MIR137 gene, increases the risk of colon and gastric cancers and can serve as a marker for susceptibility to colon and gastric cancers.</p>\",\"PeriodicalId\":9236,\"journal\":{\"name\":\"British Journal of Biomedical Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2022-02-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915678/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Biomedical Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/bjbs.2021.10095\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Biomedical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/bjbs.2021.10095","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 1
摘要
本文目的:MIR137基因在结肠癌和胃癌中起肿瘤抑制基因的作用。本研究旨在探讨MIR137上游功能可变数串联重复序列(VNTR)多态性rs58335419与结肠癌和胃癌风险的关系。材料与方法:共纳入429人,其中结肠癌患者154人,胃癌患者120人,健康对照155人。所有样品均采用PCR和电泳对目标VNTR进行基因分型。统计学分析采用SPSS 21.0软件,采用T检验、χ2检验和logistic回归检验。结果:排除罕见基因型,3/5基因型(95% CI = 1.08 ~ 3.73, OR = 2.01, p = 0.026)显著增加结肠癌的发生风险,但对胃癌无显著影响(95% CI = 0.88 ~ 3.30, OR = 1.70, p = 0.114)。此外,在VNTRs和性别的分层分析中,基因型3/4 (95% CI = 1.00-6.07, OR = 2.46, p = 0.049)和基因型3/5 (95% CI = 1.25-7.18, OR = 2.99, p = 0.014)显著增加了男性患结肠癌的风险,但在女性中没有。此外,与作为参考的3/3基因型相比,所有基因型(包括罕见基因型)发生胃癌(95% CI = 1.14-3.00, OR = 1.85, p = 0.012)和结肠癌(95% CI = 1.38-3.43, OR = 2.17, p = 0.001)的风险均显著增加。结论:MIR137基因中VNTR拷贝量的增加可增加结肠癌和胃癌的发生风险,可作为结肠癌和胃癌易感性的标志。
Significant Association of Variable Number Tandem Repeat Polymorphism rs58335419 in the MIR137 Gene With the Risk of Gastric and Colon Cancers.
The purpose of the article: The MIR137 gene acts as a tumor-suppressor gene in colon and gastric cancers. The aim of this study was to investigate the association of functional variable number tandem repeat (VNTR) polymorphism rs58335419 locating in the upstream of the MIR137 gene with the risk of colon and gastric cancers. Materials and methods: Totally, 429 individuals were contributed in the study, including 154 colon and 120 gastric cancer patients and 155 healthy controls. The target VNTR was genotyped using PCR and electrophoresis for all samples. Statistical analysis was performed using SPSS 21.0 software and by T, χ2 and logistic regression tests. Results: Excluding the rare genotypes, our results showed that genotype 3/5 (95% CI = 1.08-3.73, OR = 2.01, p = 0.026) significantly increased the risk of colon cancer but not gastric cancer (95% CI = 0.88-3.30, OR = 1.70, p = 0.114). Also, in the stratification analysis for VNTRs and sex, genotypes 3/4 (95% CI = 1.00-6.07, OR = 2.46, p = 0.049) and 3/5 (95% CI = 1.25-7.18, OR = 2.99, p = 0.014) significantly increased the risk of colon cancer in men but not in women. In addition, all genotypes including the rare genotypes as a group, significantly increase the risk of gastric (95% CI = 1.14-3.00, OR = 1.85, p = 0.012) and colon (95% CI = 1.38-3.43, OR = 2.17, p = 0.001) cancers compared to the genotype 3/3 as a reference. Conclusion: The results show that increasing the copy of VNTR in the MIR137 gene, increases the risk of colon and gastric cancers and can serve as a marker for susceptibility to colon and gastric cancers.
期刊介绍:
The British Journal of Biomedical Science is committed to publishing high quality original research that represents a clear advance in the practice of biomedical science, and reviews that summarise recent advances in the field of biomedical science. The overall aim of the Journal is to provide a platform for the dissemination of new and innovative information on the diagnosis and management of disease that is valuable to the practicing laboratory scientist.